Hemoblastosis is a group of hematologic malignancies affecting the blood, bone marrow, and lymphatic system. The identification of specific markers during a blast crisis is critical for tailoring polychemotherapy regimens. Immunophenotyping, a powerful tool in the characterization of cellular populations, allows the identification of such markers, aiding in the classification of different hemoblastoses and the selection of optimal therapeutic approaches.

Immunophenotyping, hemoblastosis, blast crisis, polychemotherapy, acute myeloid leukemia (aml), acute lymphoblastic leukemia (all), chronic myeloid leukemia (cml), flow cytometry, surface markers, biological material, leukemia classification, prognosis, treatment outcomes, bcr-abl, cd markers, personalized therapy, patient management, hematological malignancies, targeted therapy, biomarkers.

Harris. N. L., et al. (2008). *The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: An overview.* *Hematology/Oncology Clinics of North America*, 22(5), 827-840.

Davis. R. E., et al. (2011). *Immunophenotypic characterization of acute myeloid leukemia with the use of flow cytometry: Clinical and diagnostic significance.* *Journal of Hematology Oncology*, 4(1), 1-10.

Toniolo.D., et al. (2015). *Immunophenotyping in the diagnosis of acute lymphoblastic leukemia: A prospective study.* *Leukemia Research*, 39(1), 1-7.

Katz. M., et al. (2016). *The role of flow cytometry in the diagnosis and monitoring of chronic myeloid leukemia.* *Journal of Clinical Pathology*, 69(6), 501-508.

Dreyer, M., et al. (2020). *Prognostic impact of immunophenotypic features in acute leukemia: A comprehensive review.* *Cancer Treatment Reviews*, 89, 102068.

Alimoglu. O., et al. (2019). *The significance of immunophenotyping in the diagnosis and treatment of acute leukemia.* *Acta Haematologica*, 142(2), 70-78.

Crawley. C. D., et al. (2018). *Immunophenotyping and genetic profiling in acute myeloid leukemia: Implications for treatment and outcome.* *British Journal of Haematology*, 181(4), 492-503.

Baker.A. K., et al. (2020). *Immunophenotypic characterization of leukemic blasts in patients with chronic myeloid leukemia: Clinical implications.* *Leukemia Lymphoma*, 61(2), 419-426.

Абдиев, К., Махмонов, Л., Мадашева, A., & Маматкулова, Ф. (2021). Business games in teaching hematology. Общество и инновации, 2(6), 208-214

Abdiev, K. M., Makhmonov, L. S., Madasheva, O. G., & Berdiyarova, M. B. The main causes of anemia in patients with diseases of the colon. Scientist Of The XXI Century, 12;

Abdiev K.M, et al. Modern methods of treatment of hemorrhagic syndrome at an early stage in patients with idiopathic thrombocytopenic purpura // Ученый XXI века — 2021, — № 1- 1—P.41–44 (72);

Мадашева, А. Г., & Махмудова, А. Д. (2021). Биохимические показатели у больных гемофилией с мышечными патологиями до и после лечения. Форум молодых ученых, (4 (56)), 233-238.

Gazkhanovna, M. A., Makhmatovich, A. K., & Utkirovich, D. U. (2022). Clinical efficacy of extracorporeal and intravascular hemocorrection methods in psoriasis. ACADEMICIA: An International Multidisciplinary Research Journal, 12(2), 313-318.

Мадашева, А. Г. (2022). Коррекция диффузной алопеции при железодефицитной анемии. Science and Education, 3(12), 231-236.

Мадашева, А. Г. (2022). Клинико-неврологические изменения у больных гемофилией с мышечными патологиями. Science and Education, 3(12), 175-181.

Мадашева, А. Г., & Жураева, М. З. (2019). Биохимические показатели и комплексное лечение больных псориазом с лечебным плазмаферезом. Достижения науки и образования, (10 (51)), 78-82.

Махмудова АН. Правовая защита пациентов в сфере здравоохраения в новом Узбекистане. Academic research in educational sciences. 2022(1):102-7.

Махмудова АН, Махмудова С. Гуманитаризация медицинского образования как фактор повышения качества обучения в вузе. Science and Education. 2022;3(6):709-18.]

O’tayev ST, Mahmudova AN. O’zbekiston Respublikasining sog’liqni saqlash tizimida hozirgi kunda neyroxirurgiya yutuqlari. Science and Education. 2023;4(2):190-4.